MEREDITH SHEFFIELD: Open Payments
NPI 1881132769 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$812 in 37 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $111 · 2025 $812
Food & beverage: $722Education: $90
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 11 | $194 |
| Novo Nordisk Inc | 8 | $193 |
| Lilly USA, LLC | 7 | $181 |
| Biogen, Inc. | 3 | $79 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $60 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Exeltis, USA Inc. | 1 | $20 |
| Hologic Sales and Service, LLC | 1 | $18 |
Products named: Wegovy, ZEPBOUND, Veozah, ZURZUVAE, GEMTESA, Auvelity, SLYND, ACESSA PROVU SYSTEM.
Industry payments across NC — which companies pay providers there.
